Paradigm Spine Agrees to Resolve False Claims Act Allegations
Baltimore, Maryland - Medical device manufacturer Paradigm Spine has agreed to pay the United States $585,000 to resolve allegations under the False Claims Act that the company caused health care providers to submit false claims to Medicare and other federal health care programs for spine surgeries by marketing the company's coflex-F® device for surgical uses that were not approved by the U.S. Food and Drug Administration (FDA). The settlement further resolves allegations that Paradigm caused false claims by giving false recommendations on how to code health claims for procedures involving the company's coflex® device.
- Date:May 27, 2016
- Agency:U.S. Attorney
- Criminal and Civil Actions